Seebri Neohaler: An Overview of Uses, Dosage, Demographic, Side Effects, Interactions, and Generic Options Seebri Neohaler is a medication prescribed to treat chronic obstructive pulmonary disease (COPD). It is an inhaled medication that contains the active ingredient, glycopyrrolate. Glycopyrrolate works by relaxing the muscles in the airways to improve breathing. Uses Seebri Neohaler is used to treat chronic obstructive pulmonary disease (COPD). COPD is a chronic, progressive lung disease that includes emphysema and chronic bronchitis. Seebri Neohaler is used to improve breathing and reduce flare-ups in patients with COPD. Dosage The recommended dosage for Seebri Neohaler is one inhalation twice daily. The medication should be taken at the same time every day. The Neohaler device comes preloaded with the medication, and the patient just needs to inhale the medication through the device. Demographic Seebri Neohaler is approved for use in patients with COPD, including those with emphysema and chronic bronchitis. It is not approved for use in patients with asthma. Side Effects Side effects of Seebri Neohaler may include: - Dry mouth - Cough - Headache - Sore throat - Back pain - Constipation - Nausea - Muscle pain - Upper respiratory tract infection Severe side effects are rare but may include: - Allergic reaction - Swelling of the face, throat, or tongue - Difficulty breathing or swallowing - Rapid heartbeat - Dizziness or fainting Interactions Seebri Neohaler may interact with other medications, including: - Anticholinergic medications - Medications that can cause a rapid heartbeat - Medications that may increase the risk of side effects Patients should inform their healthcare provider of all medications they are currently taking before starting Seebri Neohaler. Generic Options Seebri Neohaler is the brand name for glycopyrrolate inhalation powder. There is currently no generic version of Seebri Neohaler available in the United States. However, generic versions of glycopyrrolate inhalation powder are available under other brand names. In conclusion, Seebri Neohaler is a medication prescribed for patients with COPD. It helps to improve breathing and reduce flare-ups. The recommended dosage is one inhalation twice a day. Side effects may include dry mouth, cough, headache, and more. Seebri Neohaler may interact with other medications, and there is currently no generic version available in the United States. Patients should always inform their healthcare provider of all medications they are taking before starting a new medication.